12 insiders reported 38 Form 4 transactions for Candel Therapeutics, Inc. (CADL) over the past 18 months (most recent 2026-07-01). Recent activity: Barone Francesca (Chief Scientific Officer) Sell 23,447 shares, Tyagarajan Seshu (Chief Technology Officer) Sell 7,000 shares, Manning Paul B (Director) Buy 550,458 shares, Nichols William Garrett (Chief Medical Officer) Buy 937 shares, Nichols William Garrett (Chief Medical Officer) Sell 937 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Barone Francesca | Chief Scientific Officer | Sell | 23,447 | $235,769 |
| 2026-07-01 | Tyagarajan Seshu | Chief Technology Officer | Sell | 7,000 | $70,151 |
| 2026-02-26 | Manning Paul B | Director | Buy | 550,458 | $3.0M |
| 2025-07-30 | Nichols William Garrett | Chief Medical Officer | Buy | 937 | $1,209 |
| 2025-07-30 | Nichols William Garrett | Chief Medical Officer | Sell | 937 | $6,540 |
| 2025-07-02 | Nichols William Garrett | Chief Medical Officer | Buy | 781 | $1,007 |
| 2025-07-02 | Nichols William Garrett | Chief Medical Officer | Sell | 781 | $3,936 |
| 2025-06-26 | Schoch Charles | Chief Financial Officer | Buy | 5,353 | $24,999 |
| 2025-06-26 | Barone Francesca | Chief Scientific Officer | Buy | 4,282 | $19,997 |
| 2025-06-26 | Tak Paul Peter | Chief Executive Officer | Buy | 42,826 | $199,997 |
| 2025-06-26 | Manning Paul B | Director | Buy | 1.1M | $5.0M |
| 2025-06-26 | Nabel Gary J. | Director | Buy | 5,353 | $24,999 |
| 2025-06-26 | PAPA JOSEPH C | Director | Buy | 64,239 | $299,996 |
| 2025-06-26 | Loggia Nicoletta | Director | Buy | 2,141 | $9,998 |
| 2025-06-26 | Tyagarajan Seshu | Chief Technology Officer | Buy | 5,353 | $24,999 |
| 2025-06-26 | Martell Christopher | Director | Buy | 111,349 | $520,000 |
| 2025-03-20 | Nichols William Garrett | Chief Medical Officer | Sell | 45,316 | $396,968 |
| 2025-03-20 | Tyagarajan Seshu | Chief Technology Officer | Buy | 20,000 | $25,800 |
| 2025-03-20 | Tyagarajan Seshu | Chief Technology Officer | Sell | 31,278 | $275,872 |
| 2025-03-20 | Barone Francesca | Chief Scientific Officer | Buy | 18,000 | $27,900 |
| 2025-03-20 | Barone Francesca | Chief Scientific Officer | Sell | 32,146 | $281,599 |
| 2025-03-20 | Tak Paul Peter | Chief Executive Officer | Sell | 25,772 | $226,020 |
| 2025-03-20 | Tak Paul Peter | Chief Executive Officer | Sell | 400 | $3,600 |
| 2025-03-20 | Nichols William Garrett | Chief Medical Officer | Buy | 4,584 | $17,190 |
| 2025-03-20 | Nichols William Garrett | Chief Medical Officer | Buy | 13,905 | $17,937 |
Source: SEC Form 4 filings · as of 2026-07-01